Jefferies Group's ZBIO Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 219,947 shares of Zenas BioPharma, Inc. (ZBIO) worth $4.3 M, representing 0.03% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 3 quarters.
Based on 13F filings, Jefferies Group has maintained this position in ZBIO for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 219,947 shares. Largest reduction occurred in Q2 2025, reducing 44,067 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Zenas BioPharma (ZBIO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Zenas BioPharma (ZBIO) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +219,947 | New Buy | 219,947 | $19.55 |
| Q2 2025 | -44,067 | Sold Out | 0 | $0.00 |
| Q1 2025 | +44,067 | New Buy | 44,067 | $7.90 |
Jefferies Group's Zenas BioPharma Investment FAQs
Jefferies Group first purchased Zenas BioPharma, Inc. (ZBIO) in Q1 2025, acquiring 44,067 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Zenas BioPharma, Inc. (ZBIO) for 3 quarters since Q1 2025.
Jefferies Group's largest addition to Zenas BioPharma, Inc. (ZBIO) was in Q1 2026, adding 219,947 shares worth $4.3 M.
According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 219,947 shares of Zenas BioPharma, Inc. (ZBIO), valued at approximately $4.3 M.
As of the Q1 2026 filing, Zenas BioPharma, Inc. (ZBIO) represents approximately 0.03% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Zenas BioPharma, Inc. (ZBIO) was 219,947 shares, as reported at the end of Q1 2026.